News First malaria drug for newborns and young infants cleared A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young children.
News Medical groups sue RFK Jr over COVID-19 policies Medical groups have sued HHS Secretary Robert F Kennedy Jr for removing healthy children and pregnant women from COVID-19 shot recommendations.
News Samsung builds digital health credentials with Xealth buy Samsung has reached a deal to buy Xealth, a US company set up to help healthcare professionals prescribe digital health technologies.
News Apogee rises as long-acting eczema drug heads for phase 3 Apogee shares have spiked on data showing strong efficacy with its atopic dermatitis drug and the potential for dosing just two to four times a year.
News KalVista bags FDA approval for delayed oral HAE drug KalVista has brought the first oral, on-demand treatment for hereditary angioedema attacks to the US market.
News Charities call for shake-up in UK rare disease R&D LifeArc and Genetics Alliance UK have issued a call to the government to remove obstacles impeding R&D into rare diseases.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
